Phosphodiesterase 4 (PDE4), which catalyzes the conversion of cyclic adenosine 3′,5′-monophosphate (cAMP) to 5′-AMP, contributes to the pathogenesis of AD via PAR2. This evidence concerns the gene PDE4A and Alzheimer disease.